A recent AARP study found that more than half of North Carolina’s family caregivers experienced at least one financial ...
Excerpt from ‘Cancer Gellona’, a public health awareness programme hosted by Walter Nandalike with Dr Suresh Rao, Consultant Radiation Oncologist, MIO Hospital, Mangaluru. Mangaluru, Jan 15: Cancer is ...
A clinical trial held at OU Health showed promising results for proton therapy for certain types of head and neck cancer.
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
January is the ‘Cervical Cancer Awareness Month’. You must have heard about cervical cancer? It is a cancer that begins on ...
LEGENDARY “natural mummy” Ötzi the Iceman was infected with a cancer-causing virus. The ancient human, who live around 5,300 ...
Chennai, Jan. 4 -- Highlights: ...
BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
BioAtla to retain 65% ownership of Oz-V across all solid tumor indications after completion of the SPV transaction. BioAtla will lead Phase 3 trial execution for Oz-V in OPSCC through data readout for ...
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...